solrikitug
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 26, 2024 (NCT06496607)
Timeline
No events for the selected filters.
Indications
Mechanism of action
- Cytokine receptor-like factor 2INHIBITOR
CRLF2 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314882 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06868082 | Phase 1 | May 30, 2025 | — |
| NCT06598462 | Phase 2 | Oct 16, 2024 | — |
| NCT06496620 | Phase 2 | Aug 14, 2024 | DevPro Biopharma |
| NCT06496607 | Phase 2 | Jul 26, 2024 | DevPro Biopharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DevPro Biopharma | For profit | 2 | 0 | 1 | 2024 |
1 organizations
Page 1 / 1